Back to Careers

CEO Dr. Hanadie Yousef delivered a seminar at the Buck Institute as a distinguished guest speaker highlighting Juvena’s pioneering work in regenerative biologics and AI-driven drug discovery

Back to Careers

Juvena Therapeutics presented JUV-161 and JUV-112, at ENDO2025, earning recognition from the Endocrine Society for innovation in metabolic and endocrine health

Back to Careers

Juvena Therapeutics’ Partnership with Eli Lilly Featured in Nature Biotechnology for Enhancing Muscle Health and Body Composition

Back to Careers

‘Insulin for muscle’ and the AI platform behind it, with CEO Dr. Hanadie Yousef

Back to Careers

Pharmaphorum Spotlights Juvena’s AI Platform for Muscle and Metabolic Regeneration in Interview with CEO, Dr. Hanadie Yousef

Back to Careers

Who Are Today’s Biotech Underdogs and What Will It Take for Them to Succeed?

Back to Careers

Weight Loss for Longevity? How Metabolic Drugs are Disrupting Chronic Disease and Improving Healthspan

Back to Careers

Juvena Therapeutics and Lilly Enter Research Collaboration Focused on Muscle Health

Back to Careers

Lilly Bites Again in $650M Muscle-Preserving Treatment Pact With Juvena

Back to Careers

Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs